Tirzepatide should not be used in people with type 1 diabetes
The development of small molecule angiotensin IV analogs to treat Alzheimers and Parkinsons diseases
They occur because: A smaller body needs fewer calories Metabolism adapts to defend weight The initial calorie deficit narrows over time With appropriate adjustments dietary, activity-based, or medication-related many patients can continue progress or successfully maintain their healthier weight
In June 2024, Novo Nordisk and Eli Lilly dominated the obesity market, with Novo Nordisk generating $6.3 billion and Eli Lilly $2.3 billion in sales from their weight-loss drugs in Q1 2024
The FDA issued a warning letter to an Indian API manufacturer after inspectors found that the company knowingly accepted deliberately mislabeled raw materials to bypass licensing requirements, failed to perform required identity testing, and relied on unverified supplier documentation before using the materials to manufacture APIs shipped to the United States
Easy to order, easy to inject, excellent customer service, quick delivery, controls my appetite and inspires me to make healthier choices
